On Invalid Date, Decibel Therapeutics (NASDAQ: DBTX) reported Q2 2022 earnings per share (EPS) of -$0.68, up 44.68% year over year. Total Decibel Therapeutics earnings for the quarter were -$17.05 million. In the same quarter last year, Decibel Therapeutics's earnings per share (EPS) was -$0.47.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.